Camber launches Nilotinib capsules
Camber Pharmaceuticals continues to strengthen its range of treatment options.
Camber Pharmaceuticals
Camber launches Eletriptan Hydrobromide Tablets
The tablets are indicated for the acute treatment of migraine, with or without aura, in adults.
Camber introduces Abacavir and Lamivudine Tablets, USP
Abacavir/Lamivudine Tablets, USP are indicated for treating HIV-1 infection.
Hetero and the Gates Foundation partner to expand HIV prevention access
Hetero, parent of Camber Pharmaceuticals, is a global leader in antiretroviral (ARV) therapy, supplying around 40% of worldwide HIV and AIDS medicines.
Camber adds 800 mg Darunavir tablets to product family
Darunavir Tablets are the generic equivalent of Prezista.
Camber Pharmaceuticals expands portfolio with Indomethacin suppositories
Indomethacin is a nonsteroidal anti-inflammatory drug (NSAID) indicated for the treatment of several painful and inflammatory conditions.
Camber releases Voriconazole for Injection
Voriconazole for Injection is indicated for a variety of fungal infections in adult and pediatric patients (2 years of age and older).
Camber adds Magnesium Sulfate Injection to portfolio
Magnesium Sulfate Injection, USP is suitable for replacement therapy in magnesium deficiency.
Camber launches colchicine capsules
Colchicine capsules are indicated for prophylaxis of gout flares in adults.
Camber launches metformin hydrochloride oral solution
Metformin hydrochloride oral solution is available in 500 mg/5 mL, 16 oz. bottle.
Camber launches prucalopride tablets
Prucalopride tablets are indicated for the treatment of chronic idiopathic constipation (CIC) in adults.
Camber Pharmaceuticals launches Chlorpromazine HCl Injection, USP
Chlorpromazine HCl Injection is indicated for the treatment of schizophrenia, severe behavioral problems in children, and manic-depressive illness.
Camber launches Mycophenolate Mofetil Tablets, USP
Mycophenolate Mofetil Tablets, USP are an antimetabolite immunosuppressant indicated for the prophylaxis of organ rejection.
Camber launches Olmesartan medoxomil tablets, USP
Olmesartan medoxomil tablets, USP are indicated for the treatment of hypertension in adults and children six years of age and older, to lower blood pressure.
Camber launches generic Dacogen
Decitabine for injection is available in a 50 mg single-dose vial.
Camber launches generic Stendra
Avanafil tablets is a phosphodiesterase 5 (PDE5) inhibitor indicated for the treatment of erectile dysfunction.